Print ISSN:-2394-2789

Online ISSN:-2394-2797

CODEN : IJPCN9

Article History

Received : 12-05-2023

Accepted : 08-06-2023



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 371

PDF Downloaded: 216


Navigating pharmaceutical product decisions: A comprehensive review


Full Text PDF Share on Facebook Share on Twitter


Review Article

Author Details : Mohammed Ridhan Bazil, Irshad Ibrahim N , Muhsinu Rahman, Munavar Ali, Mohammed Nihal Kottangodan, Praseen G P , Naseef PP*

Volume : 10, Issue : 2, Year : 2023

Article Page : 70-74

https://doi.org/10.18231/j.ijpca.2023.014



Suggest article by email

Get Permission

Abstract

Product management in the pharmaceutical industry is a complex and challenging role that involves overseeing the entire life cycle of a drug product, from development through commercialization and beyond. It requires a deep understanding of the regulatory environment, market dynamics, and patient needs, as well as strong leadership and management skills By classifying product decisions into these categories, businesses can prioritize their efforts and allocate resources effectively. Strategic decisions, for example, may require more resources and involve more stakeholders than operational decisions, but they can also have a greater impact on the success of the product. By making informed product line and product mix decisions, businesses can effectively meet customer needs and grow their market share. By using product portfolio analysis, businesses can make informed decisions about which products to invest in, which to divest or improve, and which new products or markets to pursue. This analysis helps businesses align their product offerings with their overall business strategy and maximize their profitability and growth potential.


Keywords: Product Mix, Product positioning, Portfolio, Branding Introduction



How to cite : Bazil M R, Irshad Ibrahim N, Rahman M, Ali M, Kottangodan M N, Praseen G P, Naseef Pp, Navigating pharmaceutical product decisions: A comprehensive review. Int J Pharm Chem Anal 2023;10(2):70-74


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.